MOVE-IT: Fear of MOVEment After MI and AF - InterneT Patient Education
Study Details
Study Description
Brief Summary
The overall aim with the project is to evaluate if a digital patient group-education can reduce kinesiophobia and promote physical activity in patients with myocardial infarction (MI) and/or atrial fibrillation (AF)
Research questions
-
Can a digital patient group-education reduce kinesiophobia and promote PA in patients with MI and/or AF?
-
Is a digital patient group-education feasible based on the patients' experiences?
Intervention: Patients with MI and/or AF and kinesiophobia meet 7 times in a group education via Zoom® video meetings with a tutor (nurse, physiotherapist) for 8 weeks and learn about PA, kinesiophobia, AF and/or CAD. The education involves four real life scenarios as a starting point for the learning process inspired by problem-based learning, live stream/recorded lectures/resource, behavioral activation and exposure to PA in order to reduce kinesiophobia and promote PA.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Early Phase 1 |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Digital patient education to reduce kinesiophobia Intervention: Patients with MI and/or AF and kinesiophobia meet 7 times in a group education via Zoom® video meetings with a tutor (nurse, physiotherapist) for 8 weeks and learn about PA, kinesiophobia, AF and/or CAD. |
Behavioral: Digital patient education to reduce kinesiophobia after MI and/or AF
Group-meetings 7 times via Zoom® video with a tutor (nurse, physiotherapist) and learn about PA, kinesiophobia, AF and/or MI. Scenarios start the problem-based learning process involving recorded lectures, behavioral activation, and exposure to PA. Week1: Programme intro. Formulation of individual goals. Home assignment (HA): Lecture PA after MI/AF. Week 2. Discuss HA. Scenario 1: Why PA after MI/AF? (PBL) Formulate questions*. HA: Answer the questions. Week 3. Follow-up HA. Scenario 2. What is MI/AF.* Week 4. Discuss HA. Scenario 3. Living with MI/AF and kinesiophobia - How to make a change?* HA: Map weekly activities, rate as frightening/non-frightening. List PA and choose one to implement. Use SMART GOALS. Lecture: Kinesiophobia. Week 5. Discuss HA. Scenario 4. How can I reduce my fear for PA.* SMART, the activity. Week 6. Discuss HA. Week 7. Own individual work. HA: Evaluate, revise, and perform activities. Week 8. Follow-up of the activity plan. Summarize the program.
|
Outcome Measures
Primary Outcome Measures
- Kinesiophobia [At baseline, after the 8-week programme and 3 months after the programme is completed.]
The Tampa Scale of Kinesiophobia Swedish Version for the Heart
Secondary Outcome Measures
- ActiGraph (accelerometer) [At baseline, after the 8-week programme and 3 months after the programme is completed.]
Patient's objective physical activity during day-time for a week
- Physical exercise behaviour [At baseline, after the 8-week programme and 3 months after the programme is completed.]
Stages of exercise behaviour change scale
- Self-efficacy [At baseline, after the 8-week programme and 3 months after the programme is completed.]
General self-efficacy scale
- Heart focused anxiety [At baseline, after the 8-week programme and 3 months after the programme is completed.]
Cardiac Anxiety scale
- Self-rated health [At baseline, after the 8-week programme and 3 months after the programme is completed.]
EQ-VAS
- Patients' experiences of the digital programme [After the 8-week programme]
Individual semi- structured interviews
Eligibility Criteria
Criteria
Inclusion Criteria:
-
patients (n=16 with MI and/or AF with kinesiophobia score of > 37.
-
Recruitment: around six months after the heart event (MI and or/AF)
Exclusion Criteria:
-
ongoing investigation of coronary artery disease and/or atrial fibrillation or other disease that results in a negative prognosis within 1 year.
-
patients who have difficulty participating in and cooperating with other people in groups due to, for example, mental illness, obvious abuse of alcohol or drugs, difficulties communicating or reading the Swedish language,
-
or participation in other studies that may affect the results are excluded.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Anita Kärner Köhler | Norrköping | Ostergotland | Sweden | 601 74 |
Sponsors and Collaborators
- Linkoeping University
- Sahlgrenska University Hospital, Sweden
- Sormland County Council, Sweden
- Kalmar County Hospital
- Region Östergötland
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- FORSS-968769
- 2023-01-20